Identification and characterization of novel TRPV4 modulators

Biochemical and Biophysical Research Communications

Volumn 389, Issue 3, 2009, Pages 490-494

  Vincent, Fabien ^a   Acevedo, Alejandra ^a   Nguyen, Margaret T ^a   Dourado, Michelle ^a   DeFalco, Jeff ^a   Gustafson, Amy ^a   Spiro, Peter ^a   Emerling, Daniel E ^a   Kelly, Michael G ^a   Duncton, Matthew A J ^a  

^a EVOTEC AG   (Germany)

Author keywords

4aPDD; Agonist; Antagonist; Ruthenium red; Tool compound; TRP channel

Indexed keywords

CAPSAZEPINE; RN 1734; RN 1747; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR AGONIST; VANILLOID RECEPTOR ANTAGONIST; SULFONAMIDE; TRPV4 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ARTICLE; CALCIUM TRANSPORT; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; HUMAN; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; ISOLATION AND PURIFICATION; MOUSE; RAT; XENOPUS;

MUS; RATTUS;

ANIMALS; HUMANS; MICE; RATS; SULFONAMIDES; TRPV CATION CHANNELS; XENOPUS;

EID: 70449732283     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.007     Document Type: Article

References (32)

1. K. Venkatachalam, C. Montell, TRP channels, Annu. Rev. Biochem. 76 (2007) 387-417.
2. N. Damann, T. Voets, B. Nilius, TRPs in our senses, Curr. Biol. 18 (2008) R880-R889.
3. B. Nilius, TRP channels in disease, Biochim. Biophys. Acta 1772 (2007) 805-812.
4. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, D. Julius, The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature 389 (1997) 816-824.
5. A. Szallasi, D.N. Cortright, C.A. Blum, S.R. Eid, The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept, Nat. Rev. Drug Discov. 6 (2007) 357-372.
6. B. Nilius, J. Vriens, J. Prenen, G. Droogmans, T. Voets, TRPV4 calcium entry channel: a paradigm for gating diversity, Am. J. Physiol. Cell Physiol. 286 (2004) C195-C205.
7. R. Strotmann, C. Harteneck, K. Nunnenmacher, G. Schultz, T.D. Plant, OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity, Nat. Cell Biol. 2 (2000) 695-702.
8. W. Liedtke, Y. Choe, M.A. Marti-Renom, A.M. Bell, C.S. Denis, A. Sali, A.J. Hudspeth, J.M. Friedman, S. Heller, Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor, Cell 103 (2000) 525-535.
9. N. Alessandri-Haber, O.A. Dina, J.J. Yeh, C.A. Parada, D.B. Reichling, J.D. Levine, Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat, J. Neurosci. 24 (2004) 4444-4452.
10. L. Birder, F.A. Kullmann, H. Lee, S. Barrick, W. de Groat, A. Kanai, M. Caterina, Activation of urothelial transient receptor potential vanilloid 4 by 4alphaphorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat, J. Pharmacol. Exp. Ther. 323 (2007) 227-235.
11. W. Liedtke, J.M. Friedman, Abnormal osmotic regulation in trpv4-/mice, Proc. Natl. Acad. Sci. USA 100 (2003) 13698-13703.
12. M. Suzuki, A. Mizuno, K. Kodaira, M. Imai, Impaired pressure sensation in mice lacking TRPV4, J. Biol. Chem. 278 (2003) 22664-22668.
13. N. Alessandri-Haber, O.A. Dina, E.K. Joseph, D. Reichling, J.D. Levine, A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators, J. Neurosci. 26 (2006) 3864-3874.
14. N. Alessandri-Haber, O.A. Dina, E.K. Joseph, D.B. Reichling, J.D. Levine, Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia, J. Neurosci. 28 (2008) 1046-1057.
15. T. Gevaert, J. Vriens, A. Segal, W. Everaerts, T. Roskams, K. Talavera, G. Owsianik, W. Liedtke, D. Daelemans, I. Dewachter, F. Van Leuven, T. Voets, D. De Ridder, B. Nilius, Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding, J. Clin. Invest. 117 (2007) 3453-3462.
16. Y. Jia, X. Wang, L. Varty, C.A. Rizzo, R. Yang, C.C. Correll, P.T. Phelps, R.W. Egan, J.A. Hey, Functional TRPV4 channels are expressed in human airway smooth muscle cells, Am. J. Physiol. Lung Cell. Mol. Physiol. 287 (2004) L272-L278.
17. F. Mizoguchi, A. Mizuno, T. Hayata, K. Nakashima, S. Heller, T. Ushida, M. Sokabe, N. Miyasaka, M. Suzuki, Y. Ezura, M. Noda, Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss, J. Cell Physiol. 216 (2008) 47-53.
18. M.J. Rock, J. Prenen, V.A. Funari, T.L. Funari, B. Merriman, S.F. Nelson, R.S. Lachman, W.R. Wilcox, S. Reyno, R. Quadrelli, A. Vaglio, G. Owsianik, A. Janssens, T. Voets, S. Ikegawa, T. Nagai, D.L. Rimoin, B. Nilius, D.H. Cohn, Gainof-function mutations in TRPV4 cause autosomal dominant brachyolmia, Nat. Genet. 40 (2008) 999-1003.
19. G. Zhu, A. Gulsvik, P. Bakke, S. Ghatta, W. Anderson, D.A. Lomas, E.K. Silverman, S.G. Pillai, Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease, Hum. Mol. Genet. (2009).
20. H. Watanabe, J. Vriens, J. Prenen, G. Droogmans, T. Voets, B. Nilius, Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels, Nature 424 (2003) 434-438.
21. P.L. Smith, K.N. Maloney, R.G. Pothen, J. Clardy, D.E. Clapham, Bisandrographolide from Andrographis paniculata activates TRPV4 channels, J. Biol. Chem. 281 (2006) 29897-29904.
22. H. Watanabe, J.B. Davis, D. Smart, J.C. Jerman, G.D. Smith, P. Hayes, J. Vriens, W. Cairns, U. Wissenbach, J. Prenen, V. Flockerzi, G. Droogmans, C.D. Benham, B. Nilius, Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives, J. Biol. Chem. 277 (2002) 13569-13577.
23. K.S. Thorneloe, A.C. Sulpizio, Z. Lin, D.J. Figueroa, A.K. Clouse, G.P. McCafferty, T.P. Chendrimada, E.S. Lashinger, E. Gordon, L. Evans, B.A. Misajet, D.J. Demarini, J.H. Nation, L.N. Casillas, R.W. Marquis, B.J. Votta, S.A. Sheardown, X. Xu, D.P. Brooks, N.J. Laping, T.D. Westfall, N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropa noyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I, J. Pharmacol. Exp. Ther. 326 (2008) 432-442.
24. S.P. Alexander, A. Mathie, J.A. Peters, Guide to receptors and channels (GRAC), third ed., Br. J. Pharmacol. 153 (Suppl. 2) (2008) S1-S209.
25. A. Yamada, O. Sato, M. Watanabe, M.P. Walsh, Y. Ogawa, Y. Imaizumi, Inhibition of smooth-muscle myosin-light-chain phosphatase by ruthenium red, Biochem. J. 349 (Pt. 3) (2000) 797-804.
26. J. Deinum, M. Wallin, P.W. Jensen, The binding of ruthenium red to tubulin, Biochim. Biophys. Acta 838 (1985) 197-205.
27. L.N. Casillas, J.U. Jeong, R.W. Marquis, Acyclic 1,3 diamines and uses therefore, (2006) patent application WO2006029210.
28. L.N. Casillas, C. Jamieson, R.W. Marquis, Novel compounds, (2006) patent application WO2006029154.
29. N. Alessandri-Haber, J.J. Yeh, A.E. Boyd, C.A. Parada, X. Chen, D.B. Reichling, J.D. Levine, Hypotonicity induces TRPV4-mediated nociception in rat, Neuron 39 (2003) 497-511.
30. S. Skogvall, M. Berglund, M.F. Dalence-Guzman, K. Svensson, P. Jonsson, C.G. Persson, O. Sterner, Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants, Pulm. Pharmacol. Ther. 20 (2007) 273-280.
31. H.J. Behrendt, T. Germann, C. Gillen, H. Hatt, R. Jostock, Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay, Br. J. Pharmacol. 141 (2004) 737-745.
32. A. Weil, S.E. Moore, N.J. Waite, A. Randall, M.J. Gunthorpe, Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8, Mol. Pharmacol. 68 (2005) 518-527.